comparemela.com

Latest Breaking News On - Alyson kuritz - Page 4 : comparemela.com

Verismo Therapeutics Receives U.S. FDA Orphan Drug Designation for SynKIR-110™, a First-in-Class KIR-CAR T Cell Immunotherapy Candidate, for the Treatment of Mesothelioma

/PRNewswire/ Verismo Therapeutics, a clinical-stage CAR-T company and Penn spinout, and pioneer of the novel KIR-CAR platform technology, today announced.

University-of-pennsylvania
Pennsylvania
United-states
Philadelphia
Bryan-kim
Alyson-kuritz
Hospital-of-the-university-pennsylvania
Drug-administration
Verismo-therapeutics
Orphan-drug-designation
Drug-designation
Prescription-drug-user-fee-act

New Global Survey Reveals Shift in Clinical Trial Priorities; Payment Efficiencies Emerge as Leading Concern for Sponsors, CROs and Sites

Nearly 800 clinical trial industry representatives from more than 50 countries shared top challenges and opportunities in Greenphire s market tren.

Germany
Australia
United-states
Canada
Poland
United-kingdom
France
Jim-murphy
Greenphire-envisi
Alyson-kuritz
Connex

EpiVario Awarded NIH Grant to Advance Research in Alcohol Use Disorder (AUD)

/PRNewswire/ EpiVario, Inc., a biotech company developing novel therapeutics for memory-related psychiatric disorders, today announced it has been awarded a.

Philadelphia
Pennsylvania
United-states
Howard-becker
Shelley-berger
Thomas-kim
Alyson-kuritz
National-institute-on-alcohol-abuse
University-of-south-carolina
Prnewswire-epivario-inc
Epivario-inc
National-institute

Verismo Therapeutics Announces Submission of IND Application to the FDA for SynKIR-110TM, a KIR-CAR T-cell Immunotherapy Candidate

/PRNewswire/ Verismo Therapeutics, a Penn-spinout and the company behind the novel KIR-CAR platform technology for CAR T-cell therapy, today announced that.

Philadelphia
Pennsylvania
United-states
Bryan-kim
Alyson-kuritz
Drug-administration
Mesothelin-expressing-advanced-ovarian-cancer
Investigational-new-drug
Verismo-therapeutics

Verismo Therapeutics Announces Research Partnership with the University of Pennsylvania

/PRNewswire/ Verismo Therapeutics, a recent University of Pennsylvania spin-out company behind the novel KIR-CAR platform technology for CAR T-cells, today.

University-of-pennsylvania
Pennsylvania
United-states
Philadelphia
Bryan-kim
Donaldl-siegel
Michaelc-milone
Alyson-kuritz
Laboratory-medicine
Penn-perelman-school-of-medicine
Research-agreement
Sponsored-research-agreement

vimarsana © 2020. All Rights Reserved.